AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 DEC 18 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNRD) announced the final results of a study at McMaster University Health Sciences Centre suggesting that use of Remune antigen in combination with oligonucleotides containing immunostimulatory CpG motifs (CpG ODN) induces HIV-specific immune responses in genital and vaginal tracts and protected animals from infection after virus challenge.
The study was designed to ascertain if this approach might be an effective means of inducing protection and potent immune responses in the genital tract against infection with HIV-1.
"Our results suggest that Remune antigen plus CpG ODN when given as a intranasal immunization can induce significant levels of HIV-specific immunity in the genital tract of mice," said Dr. Kenneth L. Rosenthal, lead investigator of the study at McMaster University Health Sciences Centre in Hamilton, Canada. "Furthermore, these animals were protected from virus challenge in the genital tract. These results suggest that a similar approach should be tested to determine if humans can be protected from sexually transmitted HIV-1 infection through a intranasal immunization."
The study, published in The Journal of Infectious Diseases (2002;186:1098-1105), evaluated vaginal and systemic immune responses and protection from vaginal challenge elicited after intranasal immunization of mice with Remune antigen in combination with CpG ODN. Mice immunized with Remune antigen plus CpG ODN had enhanced levels of anti-p24 IgG and IgA antibodies in serum and vaginal washes, and increased production of chemokines and Interferon gamma.
Further ...
Source: HighBeam Research, Study: Remune antigen with CpG ODN may offer HIV protection.